Page last updated: 2024-10-25

clofibric acid and Pancreatic Neoplasms

clofibric acid has been researched along with Pancreatic Neoplasms in 1 studies

Clofibric Acid: An antilipemic agent that is the biologically active metabolite of CLOFIBRATE.
clofibric acid : A monocarboxylic acid that is isobutyric acid substituted at position 2 by a p-chlorophenoxy group. It is a metabolite of the drug clofibrate.

Pancreatic Neoplasms: Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rao, MS1
Subbarao, V1

Other Studies

1 other study available for clofibric acid and Pancreatic Neoplasms

ArticleYear
Incidence of pancreatic and testicular tumors in rats treated with ciprofibrate, a peroxisome proliferator.
    Cancer letters, 1995, Nov-06, Volume: 97, Issue:2

    Topics: Animals; Clofibric Acid; Fibric Acids; Hypolipidemic Agents; Incidence; Leydig Cell Tumor; Male; Mic

1995